P8F-31638-95974
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 463 / IN
- Registered
- 2021-12-10
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-09
Dose 1 — Pfizer-BioNTech
-
2021-12-10
Registered in v-safe
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-16
-
2021-12-25
Survey response — day 14, dose 1MedDRA: COVID-19, Cough, Headache, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Covid positive- runny nose, cough, headache, feverMedDRA releases: 2024-11 · check-in free text available
- 2021-12-30
-
2022-01-04
Dose 2 — Pfizer-BioNTech
- 2022-01-06
- 2022-01-08
- 2022-01-09
- 2022-01-10
- 2022-01-11
- 2022-01-18
- 2022-01-25
- 2022-02-01
- 2022-02-08
- 2022-02-17
- 2022-04-05
- 2022-07-07
- 2023-01-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-09 | Pfizer-BioNTech | No |
| 2 | 2022-01-04 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 1
Symptoms: Covid positive- runny nose, cough, headache, fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release